Cargando…
Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas
MYC rearrangements usually confer aggressive biological behavior to large B-cell lymphomas. In this study, we aimed to evaluate the relevance of LMO2 detection to the clinical approach to these tumors. First, the ability of LMO2 loss of expression to recognize the presence of MYC rearrangements was...
Autores principales: | Vazquez, Ivonne, Papaleo, Natalia, Garcia, Eugenia, Salido, Marta, Salar, Antonio, Hernandez, Silvia, Calvo, Xavier, Colomo, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226002/ https://www.ncbi.nlm.nih.gov/pubmed/32260556 http://dx.doi.org/10.3390/cancers12040884 |
Ejemplares similares
-
First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma
por: Diez-Feijóo, Ramón, et al.
Publicado: (2022) -
A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma
por: Liu, Yifei, et al.
Publicado: (2019) -
Biochemical Feature of LMO2 Interactome and LMO2 Function Prospect
por: Wang, Wenhao, et al.
Publicado: (2020) -
Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds
por: Canning, Peter, et al.
Publicado: (2021) -
Value of GCET1, HGAL (GCET2), and LMO2 in the Determination of Germinal Center Phenotype in Diffuse Large B-cell Lymphoma
por: Berker, Neslihan, et al.
Publicado: (2023)